123 related articles for article (PubMed ID: 38043487)
1. High-resolution HLA genotyping in inclusion body myositis refines 8.1 ancestral haplotype association to DRB1*03:01:01 and highlights pathogenic role of arginine-74 of DRβ1 chain.
Slater N; Sooda A; McLeish E; Beer K; Brusch A; Shakya R; Bundell C; James I; Chopra A; Mastaglia FL; Needham M; Coudert JD
J Autoimmun; 2024 Jan; 142():103150. PubMed ID: 38043487
[TBL] [Abstract][Full Text] [Related]
2. Immune-Array Analysis in Sporadic Inclusion Body Myositis Reveals HLA-DRB1 Amino Acid Heterogeneity Across the Myositis Spectrum.
Rothwell S; Cooper RG; Lundberg IE; Gregersen PK; Hanna MG; Machado PM; Herbert MK; Pruijn GJM; Lilleker JB; Roberts M; Bowes J; Seldin MF; Vencovsky J; Danko K; Limaye V; Selva-O'Callaghan A; Platt H; Molberg Ø; Benveniste O; Radstake TRDJ; Doria A; De Bleecker J; De Paepe B; Gieger C; Meitinger T; Winkelmann J; Amos CI; Ollier WE; Padyukov L; Lee AT; Lamb JA; Chinoy H;
Arthritis Rheumatol; 2017 May; 69(5):1090-1099. PubMed ID: 28086002
[TBL] [Abstract][Full Text] [Related]
3. Genetics in inclusion body myositis.
Rothwell S; Lilleker JB; Lamb JA
Curr Opin Rheumatol; 2017 Nov; 29(6):639-644. PubMed ID: 28777108
[TBL] [Abstract][Full Text] [Related]
4. High-resolution HLA-DRB1 genotyping in an Australian inclusion body myositis (s-IBM) cohort: an analysis of disease-associated alleles and diplotypes.
Rojana-udomsart A; James I; Castley A; Needham M; Scott A; Day T; Kiers L; Corbett A; Sue C; Witt C; Martinez P; Christiansen F; Mastaglia F
J Neuroimmunol; 2012 Sep; 250(1-2):77-82. PubMed ID: 22633068
[TBL] [Abstract][Full Text] [Related]
5. HLA-DRB1 allele and autoantibody profiles in Japanese patients with inclusion body myositis.
Oyama M; Ohnuki Y; Inoue M; Uruha A; Yamashita S; Yutani S; Tanboon J; Nakahara J; Suzuki S; Shiina T; Nishino I; Suzuki S
PLoS One; 2020; 15(8):e0237890. PubMed ID: 32810190
[TBL] [Abstract][Full Text] [Related]
6. Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1 and -DQA1 allelic profiles and motifs define clinicopathologic groups in caucasians.
O'Hanlon TP; Carrick DM; Arnett FC; Reveille JD; Carrington M; Gao X; Oddis CV; Morel PA; Malley JD; Malley K; Dreyfuss J; Shamim EA; Rider LG; Chanock SJ; Foster CB; Bunch T; Plotz PH; Love LA; Miller FW
Medicine (Baltimore); 2005 Nov; 84(6):338-349. PubMed ID: 16267409
[TBL] [Abstract][Full Text] [Related]
7. Focused HLA analysis in Caucasians with myositis identifies significant associations with autoantibody subgroups.
Rothwell S; Chinoy H; Lamb JA; Miller FW; Rider LG; Wedderburn LR; McHugh NJ; Mammen AL; Betteridge ZE; Tansley SL; Bowes J; Vencovský J; Deakin CT; Dankó K; Vidya L; Selva-O'Callaghan A; Pachman LM; Reed AM; Molberg Ø; Benveniste O; Mathiesen PR; Radstake TRDJ; Doria A; de Bleecker J; Lee AT; Hanna MG; Machado PM; Ollier WE; Gregersen PK; Padyukov L; O'Hanlon TP; Cooper RG; Lundberg IE;
Ann Rheum Dis; 2019 Jul; 78(7):996-1002. PubMed ID: 31138531
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide association study identifies HLA 8.1 ancestral haplotype alleles as major genetic risk factors for myositis phenotypes.
Miller FW; Chen W; O'Hanlon TP; Cooper RG; Vencovsky J; Rider LG; Danko K; Wedderburn LR; Lundberg IE; Pachman LM; Reed AM; Ytterberg SR; Padyukov L; Selva-O'Callaghan A; Radstake TR; Isenberg DA; Chinoy H; Ollier WE; Scheet P; Peng B; Lee A; Byun J; Lamb JA; Gregersen PK; Amos CI;
Genes Immun; 2015 Oct; 16(7):470-80. PubMed ID: 26291516
[TBL] [Abstract][Full Text] [Related]
9. Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1, and -DQA1 allelic profiles distinguish European American patients with different myositis autoantibodies.
O'Hanlon TP; Carrick DM; Targoff IN; Arnett FC; Reveille JD; Carrington M; Gao X; Oddis CV; Morel PA; Malley JD; Malley K; Shamim EA; Rider LG; Chanock SJ; Foster CB; Bunch T; Blackshear PJ; Plotz PH; Love LA; Miller FW
Medicine (Baltimore); 2006 Mar; 85(2):111-127. PubMed ID: 16609350
[TBL] [Abstract][Full Text] [Related]
10. Cytosolic 5'-nucleotidase 1A autoimmunity in sporadic inclusion body myositis.
Larman HB; Salajegheh M; Nazareno R; Lam T; Sauld J; Steen H; Kong SW; Pinkus JL; Amato AA; Elledge SJ; Greenberg SA
Ann Neurol; 2013 Mar; 73(3):408-18. PubMed ID: 23596012
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic and prognostic value of anti-cN1A antibodies in inclusion body myositis.
Salam S; Dimachkie MM; Hanna MG; Machado PM
Clin Exp Rheumatol; 2022 Feb; 40(2):384-393. PubMed ID: 35225226
[TBL] [Abstract][Full Text] [Related]
12. Allele and haplotype frequencies of human leukocyte antigen-A, -B, -C, -DRB1, -DRB3/4/5, -DQA1, -DQB1, -DPA1, and -DPB1 by next generation sequencing-based typing in Koreans in South Korea.
Baek IC; Choi EJ; Shin DH; Kim HJ; Choi H; Kim TG
PLoS One; 2021; 16(6):e0253619. PubMed ID: 34153078
[TBL] [Abstract][Full Text] [Related]
13. Association with HLA-DRβ1 position 37 distinguishes juvenile dermatomyositis from adult-onset myositis.
Deakin CT; Bowes J; Rider LG; Miller FW; Pachman LM; Sanner H; Rouster-Stevens K; Mamyrova G; Curiel R; Feldman BM; Huber AM; Reed AM; Schmeling H; Cook CG; Marshall LR; Ll Wilkinson MG; Eyre S; Raychaudhuri S; Wedderburn LR;
Hum Mol Genet; 2022 Jul; 31(14):2471-2481. PubMed ID: 35094092
[TBL] [Abstract][Full Text] [Related]
14. HLA allele distribution distinguishes sporadic inclusion body myositis from hereditary inclusion body myopathies.
Koffman BM; Sivakumar K; Simonis T; Stroncek D; Dalakas MC
J Neuroimmunol; 1998 Apr; 84(2):139-42. PubMed ID: 9628455
[TBL] [Abstract][Full Text] [Related]
15. In adult onset myositis, the presence of interstitial lung disease and myositis specific/associated antibodies are governed by HLA class II haplotype, rather than by myositis subtype.
Chinoy H; Salway F; Fertig N; Shephard N; Tait BD; Thomson W; Isenberg DA; Oddis CV; Silman AJ; Ollier WE; Cooper RG;
Arthritis Res Ther; 2006; 8(1):R13. PubMed ID: 16507114
[TBL] [Abstract][Full Text] [Related]
16. Significance of Sjögren's syndrome and anti-cN1A antibody in myositis patients.
Levy D; Nespola B; Giannini M; Felten R; Severac F; Varoquier C; Rinagel M; Korganow AS; Martin T; Poindron V; Maurier F; Chereih H; Bouldoires B; Hervier B; Lenormand C; Chatelus E; Geny B; Sibilia J; Arnaud L; Gottenberg JE; Meyer A
Rheumatology (Oxford); 2022 Feb; 61(2):756-763. PubMed ID: 33974078
[TBL] [Abstract][Full Text] [Related]
17. Sporadic inclusion body myositis: HLA-DRB1 allele interactions influence disease risk and clinical phenotype.
Mastaglia FL; Needham M; Scott A; James I; Zilko P; Day T; Kiers L; Corbett A; Witt CS; Allcock R; Laing N; Garlepp M; Christiansen FT
Neuromuscul Disord; 2009 Nov; 19(11):763-5. PubMed ID: 19720533
[TBL] [Abstract][Full Text] [Related]
18. HLA high-resolution typing by next-generation sequencing in Pandemrix-induced narcolepsy.
Lind A; Akel O; Wallenius M; Ramelius A; Maziarz M; Zhao LP; Geraghty DE; Palm L; Lernmark Å; Larsson HE
PLoS One; 2019; 14(10):e0222882. PubMed ID: 31577807
[TBL] [Abstract][Full Text] [Related]
19. Analysis of HLA class I and II alleles in sporadic inclusion-body myositis.
Lampe JB; Gossrau G; Kempe A; Füssel M; Schwurack K; Schröder R; Krause S; Kohnen R; Walter MC; Reichmann H; Lochmüller H
J Neurol; 2003 Nov; 250(11):1313-7. PubMed ID: 14648147
[TBL] [Abstract][Full Text] [Related]
20. HLA class I (A, B, C) and class II (DRB1, DQA1, DQB1, DPB1) alleles and haplotypes in the Han from southern China.
Trachtenberg E; Vinson M; Hayes E; Hsu YM; Houtchens K; Erlich H; Klitz W; Hsia Y; Hollenbach J
Tissue Antigens; 2007 Dec; 70(6):455-63. PubMed ID: 17900288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
